Össur - Third Quarter Report 2012
12:08 EDT 23 Oct 2012 | Thomson Reuters
This article has expired, however you can still
download the PDF.
Preview:
GROWTH AFFECTED BY WEAK SALES IN AMERICAS Sales - Sales growth is 2% measured in local currency. Total sales amount to USD 99 million compared to USD 101 million in Q3'11. Sales continue to be affected by a slowdown in prosthetics sales in Americas...
Other Sources for this Article
More From BioPortfolio on "Össur - Third Quarter Report 2012"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
